Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, Şevket Erbil Ünsal, İsmail Sarı
{"title":"儿童到成人风湿病的转变:成功率,影响因素,和不断发展的诊断和治疗。","authors":"Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, Şevket Erbil Ünsal, İsmail Sarı","doi":"10.46497/ArchRheumatol.2024.10749","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to evaluate the rate of successful transitions, identify factors associated with early versus late transitions, and diagnosis and treatment changes after transition into adult rheumatology.</p><p><strong>Patients and methods: </strong>In this retrospective study, patients with childhood-onset rheumatic diseases who transitioned from pediatric to adult rheumatology care between January 2013 and January 2023 were screened for a successful transition. Successful transitions were defined as maintaining annual visits to the adult rheumatology clinic after transition. Early transition was defined as less than three months between the last pediatric and first adult rheumatology visits.</p><p><strong>Results: </strong>Out of 2,552 referred patients, 210 (8.2%) patients (117 females, 93 males; mean age: 25.2±5.6 years; range, 18 to 44 years) transitioned successfully. Juvenile idiopathic arthritis and familial Mediterranean fever were the most prevalent rheumatic diseases. The median transition time was four months (interquartile range, 1 to 13 months) in patients with successful transition, and the early transition rate was 46.7%. Receiving biologic disease-modifying antirheumatic drugs was found to be associated with early transition (28.6% <i>vs.</i> 17.0%, p=0.040), and higher education levels and familial Mediterranean fever diagnosis were found to be associated with late transition. The treatment was changed for about half of the patients after transition to adult rheumatology. Patients with juvenile idiopathic arthritis were reclassified in 25 (31.6%) patients as rheumatoid arthritis, in 22 (27.8%) patients as ankylosing spondylitis, in 20 (25.3%) patients as nonradiographic axial spondyloarthritis, and in eight (10.1%) patients as psoriatic arthritis.</p><p><strong>Conclusion: </strong>A successful transition to adult rheumatology is essential for adolescents and young adults with childhood-onset rheumatic diseases. The successful transition rate in this study was relatively low, highlighting the need for standardized transition programs.</p>","PeriodicalId":93884,"journal":{"name":"Archives of rheumatology","volume":"39 4","pages":"662-669"},"PeriodicalIF":1.1000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883249/pdf/","citationCount":"0","resultStr":"{\"title\":\"Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments.\",\"authors\":\"Tuba Demirci Yıldırım, Rana İşgüder, Ezgi Karaçura, Yeşim Erez, Balahan Makay, Fatoş Önen, Şevket Erbil Ünsal, İsmail Sarı\",\"doi\":\"10.46497/ArchRheumatol.2024.10749\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>This study aimed to evaluate the rate of successful transitions, identify factors associated with early versus late transitions, and diagnosis and treatment changes after transition into adult rheumatology.</p><p><strong>Patients and methods: </strong>In this retrospective study, patients with childhood-onset rheumatic diseases who transitioned from pediatric to adult rheumatology care between January 2013 and January 2023 were screened for a successful transition. Successful transitions were defined as maintaining annual visits to the adult rheumatology clinic after transition. Early transition was defined as less than three months between the last pediatric and first adult rheumatology visits.</p><p><strong>Results: </strong>Out of 2,552 referred patients, 210 (8.2%) patients (117 females, 93 males; mean age: 25.2±5.6 years; range, 18 to 44 years) transitioned successfully. Juvenile idiopathic arthritis and familial Mediterranean fever were the most prevalent rheumatic diseases. The median transition time was four months (interquartile range, 1 to 13 months) in patients with successful transition, and the early transition rate was 46.7%. Receiving biologic disease-modifying antirheumatic drugs was found to be associated with early transition (28.6% <i>vs.</i> 17.0%, p=0.040), and higher education levels and familial Mediterranean fever diagnosis were found to be associated with late transition. The treatment was changed for about half of the patients after transition to adult rheumatology. Patients with juvenile idiopathic arthritis were reclassified in 25 (31.6%) patients as rheumatoid arthritis, in 22 (27.8%) patients as ankylosing spondylitis, in 20 (25.3%) patients as nonradiographic axial spondyloarthritis, and in eight (10.1%) patients as psoriatic arthritis.</p><p><strong>Conclusion: </strong>A successful transition to adult rheumatology is essential for adolescents and young adults with childhood-onset rheumatic diseases. The successful transition rate in this study was relatively low, highlighting the need for standardized transition programs.</p>\",\"PeriodicalId\":93884,\"journal\":{\"name\":\"Archives of rheumatology\",\"volume\":\"39 4\",\"pages\":\"662-669\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883249/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of rheumatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46497/ArchRheumatol.2024.10749\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46497/ArchRheumatol.2024.10749","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究旨在评估成功转变的比率,确定与早期和晚期转变相关的因素,以及转变为成人风湿病后的诊断和治疗变化。患者和方法:在这项回顾性研究中,对2013年1月至2023年1月期间从儿科转为成人风湿病治疗的儿童期发病风湿病患者进行筛查,以确定是否成功过渡。成功的转换被定义为在转换后保持每年到成人风湿病诊所就诊。早期转换定义为最后一次儿科和第一次成人风湿病就诊之间少于3个月。结果:2552例转诊患者中,210例(8.2%)患者(117例女性,93例男性;平均年龄:25.2±5.6岁;范围,18至44岁)成功过渡。青少年特发性关节炎和家族性地中海热是最常见的风湿病。成功转换的患者中位转换时间为4个月(四分位数间1 ~ 13个月),早期转换率为46.7%。接受生物疾病缓解类抗风湿药物与早期转变相关(28.6% vs. 17.0%, p=0.040),高学历和家族性地中海热诊断与晚期转变相关。大约一半的患者在转为成人风湿病后改变了治疗方法。青少年特发性关节炎患者中有25例(31.6%)为类风湿关节炎,22例(27.8%)为强直性脊柱炎,20例(25.3%)为非放射性轴性脊柱炎,8例(10.1%)为银屑病关节炎。结论:成功过渡到成人风湿病是必不可少的青少年和年轻的成人儿童发病的风湿病。本研究的成功转换率相对较低,突出了标准化转换方案的必要性。
Pediatric to adult rheumatology transition: Success rates, influencing factors, and evolving diagnoses and treatments.
Objectives: This study aimed to evaluate the rate of successful transitions, identify factors associated with early versus late transitions, and diagnosis and treatment changes after transition into adult rheumatology.
Patients and methods: In this retrospective study, patients with childhood-onset rheumatic diseases who transitioned from pediatric to adult rheumatology care between January 2013 and January 2023 were screened for a successful transition. Successful transitions were defined as maintaining annual visits to the adult rheumatology clinic after transition. Early transition was defined as less than three months between the last pediatric and first adult rheumatology visits.
Results: Out of 2,552 referred patients, 210 (8.2%) patients (117 females, 93 males; mean age: 25.2±5.6 years; range, 18 to 44 years) transitioned successfully. Juvenile idiopathic arthritis and familial Mediterranean fever were the most prevalent rheumatic diseases. The median transition time was four months (interquartile range, 1 to 13 months) in patients with successful transition, and the early transition rate was 46.7%. Receiving biologic disease-modifying antirheumatic drugs was found to be associated with early transition (28.6% vs. 17.0%, p=0.040), and higher education levels and familial Mediterranean fever diagnosis were found to be associated with late transition. The treatment was changed for about half of the patients after transition to adult rheumatology. Patients with juvenile idiopathic arthritis were reclassified in 25 (31.6%) patients as rheumatoid arthritis, in 22 (27.8%) patients as ankylosing spondylitis, in 20 (25.3%) patients as nonradiographic axial spondyloarthritis, and in eight (10.1%) patients as psoriatic arthritis.
Conclusion: A successful transition to adult rheumatology is essential for adolescents and young adults with childhood-onset rheumatic diseases. The successful transition rate in this study was relatively low, highlighting the need for standardized transition programs.